🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker

RecruitingNAAges 16 Years - 50 YearsAllAbeer Ghalib Abdul-khaliq
NCT07452614 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective controlled clinical trial investigates whether metabolic biomarkers measured in pulpal blood at the time of carious pulp exposure can predict the 12-month outcomes of vital pulp treatment in symptomatic permanent teeth. Eligible patients aged 16-50 years presenting with deep carious pulp exposure will undergo vital pulp therapy (partial pulpotomy or full pulpotomy). Pulpal blood samples will be collected at the time of exposure and analyzed using High-Performance Liquid Chromatography (HPLC). Treatment outcomes will be assessed clinically and radiographically at 12 months. The study aims to identify objective, measurable biomarkers that can improve pulpal diagnosis and guide clinical decision-making in vital pulp therapy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age range of 16-50 years. 2. Pulp exposure during treatment of deep caries. 3. Absence of periodontitis or systemic disease. 4. Only one or two proximal surfaces lost with remaining walls \> 2 mm; and 5. Good compliance and signed informed consent forms. Exclusion Criteria: 1. Patients who meet any of the following criteria will be excluded: 2. Teeth with unrestorable large defects or the need for RCT for aesthetic reasons; 3. Teeth with a negative response to cold testing 4. Current pregnancy or breastfeeding; 5. Poor compliance or inability to complete the trial. 6. The use of medications, including antibiotics, bisphosphonates, or statins, within 3 weeks before the study. 7. Inadequate blood sample collection after pulpal exposure.
💊

What it tests

  • vital pulp treatment
📍

Where

1 site
College of dentistry\ University of Baghdad
Baghdad, Iraq
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy